Clinical Trial Update: Atorvastatin Three Year Pediatric Study [Phase 3]

View source ↗

Summary

Phase 3 pediatric study of atorvastatin for familial hypercholesterolemia has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2015-06-02